The Subject Expert Committee (SEC) of the Indian drug regulator will meet today to take up an application by pharma giant Dr Reddy's Laboratories seeking emergency approval for Sputnik V, the Russia-developed coronavirus vaccine. The vaccine has an efficacy of 91.6 per cent.